Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Five Things to Know About Weight-Loss Drugs and IBD

Five Things to Know About Weight-Loss Drugs and IBD
ShareXFacebook

(MedPage Today) -- As gastroenterologists seek better therapies for inflammatory bowel disease (IBD), they're closely watching the evolving data on GLP-1 receptor agonists. Could drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Your Chatbot Talking to Mine Is Not Real Healthcare
MedPage Today

Your Chatbot Talking to Mine Is Not Real Healthcare

(MedPage Today) -- Recently, a friend from the world of business told me a story. They had a new project and reached out to one of the partners from a different company to get things started, to get things rolling. They had a generative artificial...

Read more →
Advertisement